Scarica l'app Stockscreener
3.46
0.73%
0.025
Dopo l'orario di chiusura:
3.37
-0.09
-2.60%
Precedente Chiudi:
$3.435
Aprire:
$3.49
Volume 24 ore:
73,380
Relative Volume:
0.07
Capitalizzazione di mercato:
$7.84M
Reddito:
-
Utile/perdita netta:
$-12.88M
Rapporto P/E:
-1.4904
EPS:
-2.3215
Flusso di cassa netto:
$-10.85M
1 W Prestazione:
+20.14%
1M Prestazione:
-51.27%
6M Prestazione:
-34.84%
1 anno Prestazione:
-83.98%
Intervallo 1D:
$3.25
$3.5363
Intervallo di 1 settimana:
$2.82
$3.59
Portata 52W:
$2.7375
$22.80
Processa Pharmaceuticals Inc Stock (PCSA) Company Profile
Nome
Processa Pharmaceuticals Inc
Settore
Industria
Telefono
443-776-3133
Indirizzo
601 21ST STREET, SUITE 300, VERO BEACH
Confronta PCSA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PCSA
Processa Pharmaceuticals Inc
|
3.46 | 7.78M | 0 | -12.88M | -10.85M | -2.3215 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Processa Pharmaceuticals Inc Stock (PCSA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-04-25 | Iniziato | H.C. Wainwright | Buy |
Processa Pharmaceuticals Inc Borsa (PCSA) Ultime notizie
Will Processa Pharmaceuticals Inc. stock outperform value stocksLayoff News & Capital Efficiency Focused Strategies - ulpravda.ru
Processa Pharmaceuticals and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Progress Index
Processa Pharmaceuticals Regains Nasdaq Minimum Bid Compliance - TipRanks
Processa Pharmaceuticals completes enrollment for NGC-Cap breast cancer study - Investing.com Nigeria
Processa Pharmaceuticals completes enrollment of 20th patient in Phase 2 study - TipRanks
Processa Pharmaceuticals (PCSA) Advances in Phase 2 Cancer Study - GuruFocus
Processa Pharmaceuticals completes enrollment for NGC-Cap breast cancer study By Investing.com - Investing.com South Africa
Processa Pharmaceuticals Completes Patient Enrollment for Phase 2 Clinical Study of NGC-Cap in Advanced Breast Cancer, Interim Data Expected Q1 2026 - Quiver Quantitative
Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study - The Manila Times
Processa Pharmaceuticals Inc. (PCSA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
User | chroniclejournal.comProcessa Pharmaceuticals, Inc.Common Stock (Nasdaq:PCSA) Stock Quote - FinancialContent
Why did Processa Pharmaceuticals stock surge 160% today? - MSN
Oracle, Hut 8, Processa Pharmaceuticals, Recursion Pharmaceuticals, Udemy: Stocks making the biggest moves today - MSN
Processa Pharmaceuticals Inc Azioni (PCSA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.80%
4.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):